Replies to post #238522 on Biotech Values

[DewDiligence]

Good question. My guess is the efficacy (at reducing symptomatic disease) of the PFE/BNTX and MRNA vaccines in an all-comers trial conducted right now would fall somewhere in between the original JNJ number and the original PFE/BNTX and MRNA numbers.